Pharmacological Reviews Get Tables of Contents delivered automatically
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levant, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levant, B.

Vol. 49, Issue 3, 231-252, September 1997

The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance

Beth Levanta

Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas

I. Introduction
II. Molecular Biology
    A. Receptor Taxonomy
    B. Gene Organization and Receptor Synthesis
    C. Receptor Isoforms
    D. Protein Structure
III. Cellular Signaling Mechanisms
    A. Signal Transduction in Expression Systems
    B. Coupling in Brain
IV. Pharmacology
    A. Radioligand Binding Studies
    B. Functional Assays
V. Localization of D3 Receptors in Brain
    A. Distribution of D3 Receptor Messenger Ribonucleic Acid
        1. Distribution in rat brain.
        2. Distribution in human brain.
    B. Distribution of Putative D3 Receptors
        1. Distribution in rat brain.
        2. Distribution in human brain.
    C. Implications of Regional Distribution
VI. D3 Receptors in Cellular and Organismal Function
    A. Role in Behavior
    B. Role in Neuronal Activity
    C. Role in Neurochemistry
    D. Role in Development
VII. Regulation of D3 Receptor Density and Messenger Ribonucleic Acid Expression
    A. Modulation by Tonic Dopaminergic Activity
    B. Modulation by Antidopaminergic Drugs
VIII. D3 Receptors and Disease
    A. Genetic Linkage to Disease
    B. Receptor Alterations in Neuropsychiatric Disorders
IX. Conclusion
References


a   Address for correspondence: Beth Levant, Ph.D., Department of Pharmacology, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7417. 


0031-6997/97/4903-0231$03.00/0
PHARMACOLOGICAL REVIEWS
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition